P204 Fractionated Carboplatin and Vinorebine for Elderly and Poor Performance Status Patients With NSCLC

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-202678.265
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Low Resting Energy Expenditure in Middle-Aged and Elderly Hemodialysis Patients With Poor Nutritional Status

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2006English

P2.04-28 Use of Immune Checkpoint Inhibitors (ICIs) in Patients With Refractory Non-Small Cell Lung Cancer (NSCLC) and Poor Performance Status (PS)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PIG3 Promotes NSCLC Cell Mitotic Progression and Is Associated With Poor Prognosis of NSCLC Patients

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

MS18.01 Treatment of Patients With Poor Performance Status (ECOG 3-4)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Determining the Optimum Way to Maintain Quality of Life for Very Elderly Patients With Advanced Bladder Cancer and Poor Performance Status: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Comorbidity in Elderly NSCLC Patients

Thorax
PulmonaryRespiratory Medicine
2005English

Hypogammaglobulinemia and Poor Performance Status Are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients With Hematological Malignancies

Turkish Journal of Haematology
Hematology
2017English

P3.01-51 Outcomes With Systemic Chemotherapy in Advanced NSCLC Patients With Performance Status 2 and Above and Without Driver Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.16-21 Phase I / II Study of Carboplatin, Nab-Paclitaxel, and Concurrent Radiotherapy for Patients With Locally Advanced NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy